Clinical Trial Update: Phase I Study of a Vaccine for Severe Acute Respiratory Syndrome (SARS) [Phase 1]

View source ↗

Summary

A Phase I trial evaluating a vaccine for severe acute respiratory syndrome (SARS) in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syndrome

Drugs mentioned

• SARS vaccine

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Healthy | Phase 1 | Status: COMPLETED